Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Enveric Biosciences, Inc. (ENVB)
Company Research
Source: Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric”), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders, today announced that Joseph Tucker, Ph.D., Chief Executive Officer, will deliver a virtual presentation at the H.C. Wainwright 26th Annual Global Investment Conference being held September 9-11, 2024.During the presentation, Dr. Tucker will discuss the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, including its lead candidate EB-003, for which the company recently announced data confirming oral bioavailability and significant brain exposure. Additionally, Dr. Tucker will discuss Enveric’s strategy to maximize the value of the assets developed using the Company’s AI-backed drug discovery engine.Presentation Details:Event:H.C. Wainwright 26th Annual Global Investment ConferenceDate:September
Show less
Read more
Impact Snapshot
Event Time:
ENVB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENVB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENVB alerts
High impacting Enveric Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
ENVB
News
- Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results [Yahoo! Finance]Yahoo! Finance
- Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate ResultsBusiness Wire
- Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002Business Wire
- Enveric Biosciences Announces Broad Range of Patent IssuancesBusiness Wire
- Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003Business Wire
ENVB
Sec Filings
- 11/22/24 - Form 8-K
- 11/14/24 - Form 10-Q
- 11/14/24 - Form 8-K
- ENVB's page on the SEC website